Cargando…

Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) R47H Variant Causes Distinct Age‐ and Sex‐Dependent Musculoskeletal Alterations in Mice

Previous studies proposed the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2), a receptor expressed in myeloid cells including microglia in brain and osteoclasts in bone, as a link between brain and bone disease. The TREM2 R47H variant is a known risk factor for Alzheimer's disease (AD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Essex, Alyson L., Huot, Joshua R., Deosthale, Padmini, Wagner, Alison, Figueras, Jorge, Davis, Azaria, Damrath, John, Pin, Fabrizio, Wallace, Joseph, Bonetto, Andrea, Plotkin, Lilian I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307075/ https://www.ncbi.nlm.nih.gov/pubmed/35575023 http://dx.doi.org/10.1002/jbmr.4572

Ejemplares similares

miR21 deletion in osteocytes has direct and indirect effects on skeletal muscle in a sex-dimorphic manner in mice
por: Essex, Alyson L., et al.
Publicado: (2022)

MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer
por: Huot, Joshua R., et al.
Publicado: (2021)

Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice
por: Essex, Alyson L., et al.
Publicado: (2019)

Sex-specific differences in direct osteoclastic versus indirect osteoblastic effects underlay the low bone mass of Pannexin1 deletion in TRAP-expressing cells in mice
por: Deosthale, Padmini, et al.
Publicado: (2022)

Chronic Treatment with Multi-Kinase Inhibitors Causes Differential Toxicities on Skeletal and Cardiac Muscles
por: Huot, Joshua R., et al.
Publicado: (2019)

The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
por: Xiang, Xianyuan, et al.
Publicado: (2018)

Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
por: Peshoff, Mekenzie M., et al.
Publicado: (2023)

TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
por: Sun, Rui, et al.
Publicado: (2023)

Age- and sex-dependent role of osteocytic pannexin1 on bone and muscle mass and strength
por: Aguilar-Perez, Alexandra, et al.
Publicado: (2019)

TREM2 p.R47H substitution is not associated with dementia with Lewy bodies
por: Walton, Ronald L., et al.
Publicado: (2016)

The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice
por: Pin, Fabrizio, et al.
Publicado: (2022)

TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria
por: N'Diaye, Elsa-Noah, et al.
Publicado: (2009)

Association study between multiple system atrophy and TREM2 p.R47H
por: Ogaki, Kotaro, et al.
Publicado: (2018)

Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (TREM2)
por: Jones, Brandon M., et al.
Publicado: (2014)

Functional involvement of γ-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2)
por: Glebov, Konstantin, et al.
Publicado: (2016)

Trem2 Splicing and Expression are Preserved in a Human Aβ-producing, Rat Knock-in Model of Trem2-R47H Alzheimer’s Risk Variant
por: Tambini, Marc D., et al.
Publicado: (2020)

Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma
por: Ford, Jill W., et al.
Publicado: (2022)

Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental Melioidosis
por: Weehuizen, Tassili A. F., et al.
Publicado: (2016)

PGC1α overexpression preserves muscle mass and function in cisplatin‐induced cachexia
por: Huot, Joshua R., et al.
Publicado: (2022)

Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
por: Song, Wilbur M., et al.
Publicado: (2018)

The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
por: Cheng-Hathaway, Paul J., et al.
Publicado: (2018)

Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
por: Zhong, Li, et al.
Publicado: (2018)

The Triggering Receptor Expressed on Myeloid Cells 2: “TREM-ming” the Inflammatory Component Associated with Alzheimer's Disease
por: Rohn, Troy T.
Publicado: (2013)

HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia
por: Huot, Joshua R., et al.
Publicado: (2020)

6′-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor binding
por: Powell, Katherine M., et al.
Publicado: (2020)

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
por: Rayaprolu, Sruti, et al.
Publicado: (2013)

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
por: Genua, Marco, et al.
Publicado: (2014)

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
por: Ma, Li, et al.
Publicado: (2016)

The Alzheimer's Disease-Associated R47H Variant of TREM2 Has an Altered Glycosylation Pattern and Protein Stability
por: Park, Ji-Seon, et al.
Publicado: (2017)

Function of TREM1 and TREM2 in Liver-Related Diseases
por: Sun, Huifang, et al.
Publicado: (2020)

Attenuated Inflammatory Response in Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Knock-Out Mice following Stroke
por: Sieber, Matthias W., et al.
Publicado: (2013)

Maprotiline ameliorates isoflurane-induced microglial activation via regulating triggering receptor expressed in myeloid cells 2 (TREM2)
por: Hu, Rui, et al.
Publicado: (2021)

Targeting the TREM1-positive myeloid microenvironment in glioblastoma
por: Filippova, Natalia, et al.
Publicado: (2022)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

TMEM59 interacts with TREM2 and modulates TREM2-dependent microglial activities
por: Liu, Zhaoji, et al.
Publicado: (2020)

ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia
por: Huot, Joshua R., et al.
Publicado: (2020)

TREM2 in Neurodegenerative Diseases
por: Jay, Taylor R., et al.
Publicado: (2017)

Erratum to: Targeting the TREM1-positive myeloid microenvironment in glioblastoma
Publicado: (2023)

TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
por: Fan, Ruyue, et al.
Publicado: (2023)

Myeloid Trem2 Dynamically Regulates the Induction and Resolution of Hepatic Ischemia-Reperfusion Injury Inflammation
por: Han, Sheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d491ne2e7c0ubcg75lc6q28hej